ロード中...
The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
BACKGROUND: The nature and rate of gastric mucosal (GM) damage in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) remain to be among the unsolved problems. OBJECTIVE: To define the role of H. pylori and drugs in the development of GM damages in SLE and APS. METHODS: A study wa...
保存先:
| 出版年: | Int J Rheumatol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6525898/ https://ncbi.nlm.nih.gov/pubmed/31191660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9698086 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|